1.
PRESS RELEASE ACQUISITION PAION AG INTENDS TO ACQUIRE CENES ...
File Format: PDF/Adobe Acrobat Proposed transaction values CeNeS at approx. EUR 13.7 million. • Transaction unanimously recommended by CeNeS Directors. • CeNeS shareholders will receive ...
2.
PAION AG
PAION announces Phase I study with sedative/anaesthetic CNS 7056 progressed to midazolam comparison - Today company presentation at UBS Global Life Sciences ...
3.
Anschreiben Englisch
File Format: PDF/Adobe Acrobat Certificate of Deposit. Annual General Meeting of PAION AG on August 26, 2005. We herewith confirm to (please fill in) ...
4.
PAION AG
PAION and Lundbeck partner on Phase III compound Desmoteplase for acute stroke ... PAION IPO: first trading day on 11 February 2005 (only in German) ...
5.
PAION Q3#2006
File Format: PDF/Adobe Acrobat shareholders of paion ag have announced an increase of their equity stake. Innoven, a French company already invested in paion before the IPO, ...
6.
PAION AG
PAION announces Phase I study with sedative/anaesthetic CNS 7056 progressed to midazolam comparison - Today company presentation at UBS Global Life Sciences ...
7.
PAION GmbH and Forest Laboratories partner in acute
File Format: PDF/Adobe Acrobat - View as HTML AACHEN, GERMANY AND NEW YORK, NY – July 06, 2004 – PAION GmbH and. Forest Laboratories, Inc. announced today that the companies have entered into an ...
8.
PAION startet Schlaganfall-Studie in den USA
File Format: PDF/Adobe Acrobat - View as HTML PAION: Desmoteplase study in stroke completed. Hope for future of stroke treatment? Aachen (Germany), 16 October 2003 – PAION GmbH completes successfully ...
9.
Microsoft Word _ FINAL_DEDAS_Result_e_050204_doc
File Format: PDF/Adobe Acrobat International Stroke. Conference in New Orleans, Louisiana, the data of a second Phase II acute stroke trial, DEDAS, involving Desmoteplase, ...
10.